Burger R, Otte A, Brdon J, Peipp M, Gramatzki M. Dual intracellular targeting by ruxolitinib and the Mcl-1 inhibitor S63845 in interleukin-6-dependent myeloma cells blocks <i>in vivo</i> tumor growth. haematol [Internet]. 2021Sep.1 [cited 2024Apr.23];106(9):2507-10. Available from: https://haematologica.org/article/view/haematol.2020.276865